1. Introduction {#sec0005}
===============

Since the proliferation of high-throughput sequencing technologies, the search for viruses has entered a new era ([@bib0075], [@bib0080]). These technologies are capable of producing millions of sequence reads without a priori knowledge of the sample. Sequence data generated from a sample is compared to known sequence databases in order to identify viruses. Previously, virus metagenomics was accomplished by cloning and sanger-based sequencing of randomly amplified nucleic acid ([@bib0020], [@bib0040]). Despite the small amount of sequence data produced, it was still possible to detect viruses due to either high concentrations, or some process of prior enrichment being applied that removes host cells and exogenous nucleic acid.

The relative abundance of a virus (or viral nucleic acid) in a sample, compared to that of other organisms such as bacteria or host cells (or their genomes), is a critical factor for the discovery of viruses when using metagenomics. A higher proportion of viral sequence increases the probability that (1) viral sequences will be represented in a metagenomic dataset and (2) larger contigs can be assembled, increasing the likelihood of a match in the database. It is has been shown that without some type of physical enrichment method, viruses may not be present in high enough concentrations to be detected ([@bib0035]). This problem is somewhat overcome as high-throughput sequencing technologies advance in both read length and sequencing depth. Nevertheless, gains in sensitivity are still possible by the application of a physical enrichment process for viruses, and may also avoid the cost of generating and analysing additional data.

In the field of viral ecology there have already been significant advances in the validation of physical enrichment methods for viruses ([@bib0045], [@bib0065]), such as the methods used to concentrate and purify viruses from seawater for virus discovery by metagenomics ([@bib0050]). However, only a few methodological studies have been applied to evaluate the efficiency of viral enrichment methods in metagenomics that seek to diagnose animal or human disease. A study on human liver tissue compared enrichment techniques of freeze--thaw, centrifugation and nuclease-treatment for the detection of Hepatitis C Virus using both Roche 454 and Illumina high-throughput sequencing platforms ([@bib0035]). The abundance of viral sequences in each treatment group was compared to results obtained by quantitative real-time PCR detection of transcripts, and the effect of each treatment method on viral genome coverage was also determined. Such studies show that physical enrichment methods do increase the sensitivity of detection for viruses in metagenomics.
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The application of virus discovery methods using metagenomics has been considered for routine use in diagnostic and reference laboratories to aid in the diagnosis of human ([@bib0125]) and animal disease ([@bib0010]). The application of these techniques in a clinical setting will require that any virus enrichment methods are simple to perform, fast, robust, effective, standardised and do not require significant capital expenditure. It is noted that the vast majority of the published studies in [Table 1](#tbl0005){ref-type="table"} apply the simple enrichment techniques without any a priori justification for the selection of the technique. This study sought to examine the rapid and simple enrichment techniques for viruses that appear to be in routine use in the literature for diagnosing animal and human diseases, but for which the effects on metagenomic data have not been studied. This was achieved by examining the effect of these enrichment methods on the relative abundance of viruses in a metagenomic dataset derived from a simple and well-characterised artificial sample.

2. Materials and methods {#sec0010}
========================

2.1. Generation of an artificial sample containing bacteria, human cells and viruses {#sec0015}
------------------------------------------------------------------------------------

Human enterovirus 71 was cultured in human rhabdomyosarcoma cell line in Hanks MEM (Life Technologies, Carlsbad, CA, USA) supplemented with 5% foetal bovine serum (Thermofisher Scientific, Waltham, MA, USA). Human adenovirus 5 was also cultured in the human rhabdomyosarcoma cell line. Influenza A(H1N1)pdm09 was cultured in MDCK-SIAT1 cells (canine) in R-Mix (Diagnostic Hybrids, Athens, OH, USA). All virus cultures were composed of cell culture supernatant and monolayer present after freeze--thaw. *Escherichia coli* O157 was cultured in Brain Heart Infusion broth (BHI) and incubated at 37 °C overnight. Human A549 cells were cultured in DMEM (Life Technologies, Carlsbad, CA, USA) supplemented with 5% foetal bovine serum (Thermofisher Scientific, Waltham, MA, USA).

An artificial sample was formulated to consist of known amounts of *E. coli* O157, A549 human epithelial lung carcinoma cells (ATCC CCL-185), human enterovirus 71, human adenovirus 5 and influenza A(H1N1)pdm09. Aliquots of the final dilution were subjected to three freeze--thaw cycles and were frozen and stored at −80 °C.

2.2. Virus enrichment methods {#sec0020}
-----------------------------

Based upon a review of enrichment methods presented in [Table 1](#tbl0005){ref-type="table"}, five combinations of three simple methods of enrichment were selected and performed on 1 mL aliquots of the artificial sample as follows; low-speed centrifugation in a microfuge at 6000 ×  *g* for 10 min at 4 °C, sterile syringe filtration at 0.45 μm, nuclease treatment using 0.1 U μL^−1^ Turbo DNAse (Life Technologies, Carlsbad, CA, USA), 0.1 U μL^−1^ RNAse One (Promega, Fitchburg, WI, USA) and 1X DNAse buffer (Life Technologies, Carlsbad, CA, USA) and incubation at 37 °C for 90 min, or combinations of these being a 2-step method (centrifugation followed by filtration), or 3-step (centrifugation, filtration then nuclease-treatment). Independent duplicates for each treatment were performed and used in all subsequent experiments.

2.3. Nucleic acid preparation {#sec0025}
-----------------------------

The extraction of RNA was achieved using the iPrep PureLink Virus Kit (Life Technologies, Carlsbad, CA, USA), where 400 μL of the artificial sample was extracted and eluted into 100 μL of molecular-biology grade water.

2.4. Quantitative real-time PCR assays {#sec0030}
--------------------------------------

All real-time quantitative PCR assays (qPCR) were performed on a Stratagene Mx3000P Real-Time PCR System (Agilent Technologies, Santa Clara, CA, USA). qPCR on extracted RNA was used to quantify A549 human cells, influenza, adenovirus, *E. coli* O157 and enterovirus present in the artificial sample.

The human RNase P (RNP) gene was used as a target for the detection of human A549 cellular RNA. The nucleoprotein gene target was used for the detection of influenza A(H1N1)pdm09 RNA. Both assays were performed using the AgPath One Step RT-PCR Kit reagents (Life Technologies, Carlsbad, CA, USA) and the primers and probes for these assays have been previously described ([@bib0160]). Each 25 μL reaction contained 5 μL of nucleic acid, 12.5 μL of RT-PCR Buffer, 1 μL of 25X RT-PCR Enzyme Mix, 0.1 μM probe and 0.4 μM primers. Following an initial 30 min reverse transcription step at 50 °C and 10 min denaturation step at 95 °C, a 2-step cycling procedure of denaturation at 95 °C for 15 s with annealing and extension at 55 °C for 30 s over 40 cycles was used.

Adenovirus DNA was detected using a previously published assay ([@bib0025]) and the AgPath One Step RT-PCR Kit (Life Technologies, Carlsbad, CA, USA). Each 25 μL reaction contained 5 μL of DNA, 12.5 μL of RT-PCR Buffer, 1 μL of 25X RT-PCR Enzyme Mix, 0.4 μM probe and 0.5 μM primers. After an initial 10 min reverse transcription step at 45 °C and 10 min denaturation step at 95 °C, a 2-step cycling procedure of denaturation at 95 °C for 15 s with annealing and extension at 55 °C for 1 min over 45 cycles was used.

Enterovirus RNA was detected using a previously described assay ([@bib0105]) and the SuperScript III Platinum One-Step System (Life Technologies, Carlsbad, CA, USA). Each 25 μL reaction contained 5 μL of RNA, 12.5 μL of 2X Invitrogen Reaction Mix, 0.5 μL of 50 mM MgSO~4~, 0.5 μL of SuperScript^®^ III RT/Platinum^®^ *Taq* Mix, 0.1 μM probe and 0.4 μM primers. Following an initial 30 min reverse transcription step at 50 °C and 2 min denaturation step at 95 °C, a 3-step cycling procedure of denaturation at 95 °C for 15 s, annealing at 55 °C for 45 s and extension at 72 °C for 10 s over 45 cycles was used.

For *E. coli* O157 a one-step assay was performed using the LightCycler^®^ 480 Probes Mastermix (Roche, Indianapolis, IN, USA) as previously described ([@bib0110], [@bib0135]). Each 20 μL reaction contained 2 μL of DNA, 10 μL of LightCycler^®^ 480 Probes Master, 0.2 μM probe (*stx1*) and 0.5 μM primers (O0218 and O0220). Following an activation step of 95 °C for 2 min, a 3-step cycling procedure of denaturation at 95 °C for 10 s, annealing at 54 °C for 15 s and extension at 72 °C for 15 s over 45 cycles was used.

Every assay included negative and positive controls, and RNase-free reagents and handling procedures. The real-time PCR assays were made quantitative by including a dilution series of a plasmid with known copy number, which contained concatenated primer--probe--primer target sequences for each of the five assays.

2.5. Metagenomic sequencing {#sec0035}
---------------------------

DNA was co-purified with RNA during the nucleic acid extraction method, and thus DNA was removed using Ambion DNA-free (Life Technologies, Carlsbad, CA, USA), then 8 μL of this RNA was reverse transcribed into cDNA using a first-strand cDNA synthesis kit primed by random hexamers as per the manufacturer\'s instructions (Life Technologies, Carlsbad, CA, USA) including the recommended RNase H digestion. The minimum 1 μg amount of DNA required for input into the Illumina TruSeq DNA library preparation protocol was not achieved. Amplification of the cDNA was achieved by using a Whole Transcriptome Amplification kit (Qiagen, Valencia, CA, USA) as described previously ([@bib0015], [@bib0030]). Briefly, the reverse transcription step required in the kit was not utilised, but the ligation and amplification steps were followed as per the manufacturer\'s instructions except that the ligation reaction was terminated by heating to 95 °C for 5 min, and the amplification step was performed for 2 h followed by termination of the reaction at 65 °C for 3 min. For each sample more than 1 μg of DNA was produced and this was sequenced on an Illumina MiSeq instrument (New Zealand Genomics Limited, Massey Genome Service, Massey University, Palmerston North, New Zealand) using an Illumina TruSeq DNA library preparation (Illumina, San Diego, CA, USA). Water-only negative controls failed to amplify any DNA.

3. Bioinformatic analysis {#sec0040}
=========================

Illumina MiSeq sequence data consisted of 150 bp paired-end reads. Quality checking and redundant-read collapsing was performed and sequence reads were then compared to the NCBI non-redundant nucleotide database (downloaded from NCBI FTP site in February 2013) using BLASTN (BLAST+ 2.26). An E value of 0.0001 was used as the cut-off threshold value for significant hits. The BLASTN output files were imported and parsed in MEGAN 4 ([@bib0055]) for taxonomic assignment.

4. Results {#sec0045}
==========

4.1. Abundance of RNA targets as measured by quantitative real-time PCR detection {#sec0050}
---------------------------------------------------------------------------------

The abundance of nucleic acid from the model organisms in the artificial sample (human cells, bacteria, influenza, adenovirus and enterovirus) was determined by using quantitative real-time PCR. The effect of different enrichment methods on target gene copy number was assessed ([Fig. 1](#fig0005){ref-type="fig"} ). In general, all enrichment methods decreased the quantity of every model organism when compared to no treatment at all. Human RNA was removed to a limited extent by all the methods, with the 3-step treatment and nuclease-only treatments being the most effective, resulting up to 100-fold reduction in copy number. Similarly, some bacterial nucleic acid was removed by all of the enrichment methods, with the nuclease-only or the 3-step treatment being the most effective.Fig. 1Amount of model organisms detected using quantitative real-time PCR, when different virus enrichment methods are applied. Amounts are measured as copy number of a target gene, represented as log~10~ values. The average of two independent replicates are shown, with two PCR tests performed per replicate. Error bars show the 95% confidence interval. The grey line represents the copy number of the target gene when no enrichment method is applied.

The three viruses used in this experiment represent a DNA virus (adenovirus), and two RNA viruses one of which is enveloped (influenza) and the other non-enveloped (enterovirus). The subsequent metagenomic analysis was targeted at the detection of RNA viruses, but a DNA virus was included to assess the potential to detect DNA viruses using this methodology. Each virus also represented a different level of concentration (1) a high concentration at 2 × 10^6^ copies (enterovirus), (2) a moderate concentration (adenovirus) at 50,000 copies and (3) a low concentration (influenza) at 7,000 copies. All viruses showed a decrease in copy number when an enrichment method was applied. This decrease was consistent across all enrichment methods, with most showing no greater than a 10-fold reduction in copy number except the 3-step method when applied to enterovirus, where the virus copy number was reduced by 100-fold.

4.2. Relative abundance of organisms in the metagenomic dataset {#sec0055}
---------------------------------------------------------------

The same RNA extraction that was used for the qPCR was also used for a metagenomics experiment ([Fig. 2](#fig0010){ref-type="fig"} and [Table 2](#tbl0010){ref-type="table"} ). The first replicate sample of each treatment was indexed and run on one Illumina MiSeq run producing 5,913,177 sequence reads of 150 bp in length, the second replicate set was indexed and run on an independent Illumina MiSeq run and produced 12,664,374 sequences reads of 150 bp in length. After submission to BLASTN, each sequence read was given a taxonomic assignment using MEGAN.Fig. 2Relative abundance of taxonomically assigned sequence reads in the viral metagenomic sequence dataset, shown for different enrichment methods. Average values are shown for two independent replicates, and error bars represent the 95% confidence interval.Table 2Quantity and proportion of sequence reads with a positive BLASTN hit against the model organism groups used in the virus discovery metagenomic dataset, comparing the effect of different virus enrichment methods.TreatmentTotal number of sequence reads[a](#tblfn0005){ref-type="table-fn"}Metazoa*Enterobacteriaceae*AdenovirusInfluenzaEnterovirusBLASTN hits% totalBLASTN hits% totalBLASTN hits% totalBLASTN hits% totalBLASTN hits% totalNo treatment1,980,87839,4811.99%1,523,51476.9%400.002%200.001%3,2210.16%Centrifuge2,010,71748,7192.42%1,486,12573.9%00.000%770.004%14,8050.74%Filtration1,941,62665,7463.39%1,334,43368.7%60.000%1100.006%22,7311.17%Nuclease1,821,8285,1480.28%1,421,26878.0%170.001%140.001%2,5320.14%2-step treatment[b](#tblfn0010){ref-type="table-fn"}1,730,56953,4213.09%1,199,23269.3%140.001%570.003%18,7121.08%3-step treatment[b](#tblfn0010){ref-type="table-fn"}1,417,80326,8561.89%857,87360.5%160.001%1610.011%67,2274.74%[^7][^8]

All five model organisms were represented in the untreated samples ([Fig. 2](#fig0010){ref-type="fig"} and [Table 2](#tbl0010){ref-type="table"}) and for simplicity of data representation the family level of *Enterobacteriaceae* was chosen to represent the *E.coli* organism in the sample, which was the most abundant taxa identified accounting for 76.9% of the total sequences (1,523,514 reads; [Table 2](#tbl0010){ref-type="table"}). The kingdom level of Metazoa was chosen to represent the human cells within the untreated sample, which accounted for 2% of the total reads (39,481 reads; [Table 2](#tbl0010){ref-type="table"}). The decision to use Metazoa and *Enterobacteriaceae* was made to facilitate simple representation of the data, but was arbitrary, as the aim of this experiment was to compare variations in the proportions of bacteria, human cells and viruses between the enrichment methods. Viruses were present in the untreated sample in the following proportions; enterovirus 0.2% (3,221 reads), adenovirus 0.002% (40 reads) and influenza virus 0.001% (20 reads). It is interesting that the DNA virus, adenovirus, was identified in the dataset, given that the method was targeted at RNA viruses. The remainder of reads (21.1%) that were not assigned to these aforementioned taxa were accounted for as either (1) no hit in the blast search, (2) no clear taxonomic assignment from the blast search due to the stringency of parameters required by MEGAN for taxonomic assignment (3) low complexity sequence (4) assignment to a taxonomic level that was not captured by *Enterobacteriaceae*, Metazoa or viruses.

The enrichment techniques did not greatly change the relative abundance of *Enterobacteriaceae*, at best there was a 15% reduction in the number of reads assigned to this taxon when applying the 3-step treatment. There was an increase in the proportion of Metazoa sequences when filtration was applied increasing from 2% to 3.3%, with only the nuclease-treatment showing the greatest effect reducing Metazoan sequence to 0.3% (a 6-fold reduction).

For viruses, the 3-step treatment was the only treatment to show a significant increase in the proportion of viral sequence, by 10-fold for influenza (from 0.001% to 0.01%) and 20-fold for enterovirus. The proportion of adenovirus hits appeared unaffected by all enrichment methods ([Fig. 2](#fig0010){ref-type="fig"}).

5. Discussion {#sec0060}
=============

This study compares the effect of five different viral enrichment methods on the ability to detect viruses in a metagenomic approach. Enrichment techniques were deliberately chosen that have been commonly referenced in previous metagenomic studies which seek to identify new or rare viruses ([Table 1](#tbl0005){ref-type="table"}). These enrichment methods are often selected without prior justification. The effect of these enrichment techniques was examined by application to a highly specific artificial sample. This study does not provide a full validation of the enrichment methods, but highlights some possible risks if an enrichment method is selected based solely upon methods published by others and without consideration for the sample being examined.

Validation of enrichment techniques in the field of virus ecology is well developed ([@bib0045], [@bib0065]), but there is a paucity of data on the validation of enrichment methods applied to the detection of viruses in animal or human samples for the purpose of diagnosis. In the present study, an artificial sample was composed which represents the type of organisms that could possibly be observed in clinical samples i.e. a rectal swab taken from a human patient. Of course, the artificial sample is unlikely to have similar characteristics to complex biological samples from humans or animals. Bacteria are often a very abundant organism in de novo metagenomic datasets, and host sequence is also often present. To this end, *E.coli* and a human cell line were chosen, as well as two RNA viruses (influenza virus, enterovirus) and a DNA virus (adenovirus). The DNA virus was included to assess the potential for detection when using an RNA virus targeted approach, as many virus discovery projects have to create two workflows to independently target DNA or RNA viruses. Differing amounts of each virus were placed into the artificial sample so as to represent varying concentrations. This artificial sample represents a starting point to evaluate simple and rapid viral enrichment methods for use in virus metagenomics studies that seek to detect a virus that is causing disease in humans or animals. At present, there is little guidance for researchers seeking to work in this area and published studies have often selected these simple enrichment techniques with no justification for their inclusion in the method.

In general, it was observed that the choice of enrichment method such as low speed centrifugation, syringe-based filtration, nuclease treatment (DNase and RNase) or combinations of these methods, did not substantially increase the relative abundance of viruses in this metagenomics dataset, except in selected cases. Despite reductions in the quantity (copy number) of bacterial and human RNA gene targets as shown in the qPCR data, this did not translate into a substantially increased relative abundance for viral sequences in the metagenomic data. The qPCR method detects the absolute quantity of genome target present, whereas the metagenomic data is proportional (relative abundance). Even though large gains can be made in reducing bacteria and human nucleic acid, the proportion of viral sequences in the metagenomic datasets still remained relatively low (i.e. generally less than 1%) except for when a 3-step enrichment method was applied. Nevertheless, individual enrichment methods did have some effect on relative abundance of the model organisms' representation in the metagenomics data. Nuclease treatment alone was successful in reducing the proportion of human (Metazoa) sequences by 10-fold. It is hypothesised that the initial freeze--thaw processing of the artificial sample has lysed human cells and thus liberated human genome. This exogenous nucleic acid is more susceptible to digestion by nuclease than the protected bacterial and viral genomes, which are protected by membranes or capsids, which are more resistant to freeze--thaw action.

The 3-step treatment was particularly effective at increasing the abundance of both influenza and enterovirus, both in absolute concentration as measured by real-time PCR, and also relative abundance as measured in the metagenomics data. This finding supports the use of the 3-step procedure for virus enrichment, and similar 3-step procedures have previously been employed in published virus metagenomic studies ([Table 1](#tbl0005){ref-type="table"}).

Regarding sensitivity, without an enrichment method 5 × 10^3^ copies of influenza virus genome were detected using a metagenomic approach (20 sequence reads; [Table 2](#tbl0010){ref-type="table"}), and the detection of the DNA genome of adenovirus present at 10 × 10^4^ copies (3221 sequence reads; [Table 2](#tbl0010){ref-type="table"}) was also possible. This experiment was targeted at the discovery of RNA viruses but included the DNA virus (adenovirus) to determine if an RNA virus detection method could also co-detect DNA viruses. Given that the starting material used for this experiment is RNA, it is possible to surmise that adenovirus mRNA expressed during infection was detected. However, this may not be the correct explanation as the DNAse treatment used before cDNA synthesis is known to be less than 100% efficient, and some DNA is likely to have been carried right through into the sequencing library preparation. The ability to detect DNA viruses when using an RNA-targeted method will also no doubt be influenced by the specific replication cycle of any given virus.

It is noted that the viral metagenomic method chosen uses multiple displacement amplification, and therefore there is likely to be a bias in the amplification of larger genomes e.g. bacteria and host, which could confound results when considering the relative abundance of sequences in the metagenomic data. There are many different methods of amplification that are available and this represents only one. However, this amplification method is one that is in practical use, and has been applied in other virus discovery studies ([@bib0030]), therefore the examination of enrichment techniques using this specific amplification method are still relevant. There is a certainly a need for future studies to expand this work into a full validation, so as to examine the effect of enrichment when using other amplification methods i.e. SISPA, nextera, LAMP, LASL. It would also be interesting to include a greater array of enrichment methods, sample types, sequencing platforms and bioinformatics approaches which may include the incorporation of sequence assembly methods, or the use of other search algorithms. The findings presented here should provide a starting point for those considering the use of rapid or simple enrichment methods for the purposes of diagnosing new viral diseases in human or animal samples by using metagenomics. This study also highlights the possible risks of arbitrarily selecting an enrichment method purely based upon previously published studies.
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[^7]: Combined total number of sequence reads for two independent physical replicates which were also run on different Illumina MiSeq flowcells. This figure represents the collapsed sequencing data, therefore redundant reads are not represented more than once.

[^8]: Serial applications of treatment methods. The 2-step method consisted of centrifugation then filtration. The 3-step method consisted of centrifugation, filtration then nuclease-treatment.
